We’re Standing Tall against the impact of CLI

On a mission to change the stats—and the status—of CLI amputations

Micro Medical Solutions was formed to do exactly what our name implies—provide solutions to some of the most pressing unmet needs in microvascular intervention.

Our purpose is to give physicians the minimally invasive tools and technology they need to fight the impact of CLI, to significantly reduce the rate of amputations, to improve clinical outcomes and patient quality of life, and to minimize the financial and human costs associated with the treatment of PAD and CLI.


The goal of better BTK intervention

Micro Medical Solutions has set ambitious goals:

  • We are committed to reduce the number of preventable amputations, thereby reducing the significant morbidity, mortality, and burden of CLI amputations.
  • We’re not just asking important questions in BTK intervention—we’re working on the solutions right now.

Could CLI cases have a different outcome with improved treatment options?

Are we doing everything we can to prevent the cascade that leads to amputations?

How can we look at the problem differently and develop better treatment options?

What if BTK intervention could actually start BTK?

We are dedicating more focus on finding specific solutions for better access to long lesions and CTOs in the peripheral arteries. Developing an innovative pedal access platform with an industry-leading small guide is just one way we are working on the solutions.

See more about our progress here.


Visionary leadership and experience

The Micro Medical Solutions leadership team represents a combined 100 years of experience in interventional technology and procedures.

Experience matters, but the ability to develop future BTK solutions matters even more

Greg Sullivan, Founder and CEO, leads the MMS management team. Mr. Sullivan has extensive experience in the Medical Device Industry with over 25 years in the minimally invasive neurology and cardiology market.

Jihad Mustapha, MD, Chief Medical Officer, is an interventional cardiologist who specializes in endovascular revascularization of PVD: specifically, CLI. He is the co-founder and CEO of Advanced Cardiac and Vascular Amputation Prevention Centers in Grand Rapids, Michigan. He also serves as Clinical Associate Professor of Medicine at Michigan State University College of Osteopathic Medicine. Dr. Mustapha speaks internationally on the topic of CLI, alternative access, atherectomy, vessel morphology, calcification and drug eluting technology.

Greg Mathison, VP of Regulatory Affairs, has more than 35 years of experience in the healthcare industry and has supported the regulatory pathway for 510k approval for more than 200 product submissions to the FDA. He also has been instrumental in the submission of IDE and PMA applications to the FDA, as well as technical dossiers to foreign governments for CE Mark approval.

Dawn Davila, VP of Engineering and Operations, joined MMS at it’s inception as a Program Manager. Her background in neuro and peripheral vascular disease treatment along with her leadership in developing and promoting a culture of innovation with the philosophy of being thought leaders in the treatment of BTK disease, earned her the position of VP of Engineering and Operations.

Rita Jacob, Clinical Affairs Strategist, joined MMS in 2022. She brings a history of collaborating with medical device company executives and key stakeholders to deliver results in FDA regulated clinical research, medical training and scientific marketing. After spending nearly a decade in cardiovascular intensive care nursing, Rita evolved her passion for exceptional patient care to delivering novel high-risk medical devices into physicians’ hands for over 25 years. Her career has included Fortune 100 and 500 companies as well as many start-up companies. Team focus, results orientation and ethical behavior is her ethos.

Kathleen Dennis, Senior VP of Operations, joined Micro Medical Systems in June 2023, bringing with her over 25 years of proven senior leadership experience assisting emerging medical device and pharmaceutical companies with strategy, implementation of business infrastructure and building key supply chain partnerships.

Scientific Advisory Board

Andrej Schmidt, MD
University Hospital of Leipzig
Leipzig, Germany

Craig Walker, MD
Founder, President and Medical Director
Cardiovascular Institute of the South
Houma, LA

New Cardiovascular Horizons

Mahmood K. Razavi, MD
Medical Director
Comprehensive Aortic Center
Director, Department of Clinical Trials
St. Joseph Heart & Vascular Center
Orange, CA

Marco Manzi, MD
Director of Interventional Radiology
Policlinico Abano Terme
Abano Terme, Italy

Marianne Brodmann, MD
Professor of Internal Medicine
Division of Angiology
Medical University Graz
Graz, Austria

Robert Beasley, MS, MD
Director of Vascular/Interventional
Radiology and Vein Treatment Center
Mt. Sinai Medical Center
Miami Beach, FL

Thomas Zeller, MD, PhD
Department of Angiology
Clinic Cardiology-AngiologyII
University Heart Center
Freiburg-Bad Krozingen, Germany

Back To Top